FDA Approved: EDURANT — Supplemental Application (Janssen Products, LP)

View source ↗

Summary

The FDA approved a supplemental application for Edurant (rilpivirine hydrochloride) submitted by Janssen Products, LP.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Edurant (rilpivirine)

Snippet

SUPPL AP for EDURANT (RILPIVIRINE HYDROCHLORIDE)